Zobrazeno 1 - 10
of 3 544
pro vyhledávání: '"Labrie C"'
Autor:
van Elsas MJ; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden 2333ZA, the Netherlands., Middelburg J; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden 2333ZA, the Netherlands., Labrie C; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden 2333ZA, the Netherlands., Roelands J; Department of Pathology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands., Schaap G; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden 2333ZA, the Netherlands., Sluijter M; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden 2333ZA, the Netherlands., Tonea R; Department of Pathology, University of Chicago, Chicago, IL 60637, USA; Pritzker School of Molecular Engineering, Chicago, IL 60637, USA., Ovcinnikovs V; Genmab, Utrecht 3584CT, the Netherlands., Lloyd K; Genmab, Utrecht 3584CT, the Netherlands., Schuurman J; Genmab, Utrecht 3584CT, the Netherlands., Riesenfeld SJ; Pritzker School of Molecular Engineering, Chicago, IL 60637, USA., Gajewski TF; Department of Pathology, University of Chicago, Chicago, IL 60637, USA., de Miranda NFCC; Department of Pathology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands., van Hall T; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden 2333ZA, the Netherlands., van der Burg SH; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden 2333ZA, the Netherlands. Electronic address: shvdburg@lumc.nl.
Publikováno v:
Cancer cell [Cancer Cell] 2024 Jun 10; Vol. 42 (6), pp. 1032-1050.e10. Date of Electronic Publication: 2024 May 16.
Autor:
Groeneveldt C; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands., Kinderman P; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands., Griffioen L; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands., Rensing O; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands., Labrie C; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands., van den Wollenberg DJM; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands., Hoeben RC; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands., Coffey M; Oncolytics Biotech Incorporated, Calgary, Canada., Loghmani H; Oncolytics Biotech Incorporated, Calgary, Canada., Verdegaal EME; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands., Welters MJP; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands., van der Burg SH; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands., van Hall T; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands., van Montfoort N; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2024 Mar 04; Vol. 12 (3), pp. 334-349.
Autor:
van Elsas MJ; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Labrie C; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Etzerodt A; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Charoentong P; Department of Medical Oncology, National Center for Tumor Diseases, University Hospital Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany., van Stigt Thans JJC; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Van Hall T; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., van der Burg SH; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands shvdburg@lumc.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Mar; Vol. 11 (3).
Autor:
Groeneveldt C; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands., van Ginkel JQ; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands., Kinderman P; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands., Sluijter M; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands., Griffioen L; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands., Labrie C; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands., van den Wollenberg DJM; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands., Hoeben RC; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands., van der Burg SH; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands., Ten Dijke P; Department of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands., Hawinkels LJAC; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands., van Hall T; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands., van Montfoort N; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2023 Feb 23; Vol. 3 (2), pp. 325-337. Date of Electronic Publication: 2023 Feb 23 (Print Publication: 2023).
Autor:
Labrie, F.1 (AUTHOR), Labrie, C.2 (AUTHOR)
Publikováno v:
Climacteric. Apr2013, Vol. 16 Issue 2, p205-213. 9p.
Publikováno v:
Journal of Neuroendocrinology. Aug2001, Vol. 13 Issue 8, p678-682. 5p. 4 Black and White Photographs, 2 Graphs.
Autor:
Groeneveldt C; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Kinderman P; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., van Stigt Thans JJC; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Labrie C; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Griffioen L; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Sluijter M; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., van den Wollenberg DJM; Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands., Hoeben RC; Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands., den Haan JMM; Molecular Cell Biology and Immunlogy, Amsterdam UMC - Location VUMC, Amsterdam, The Netherlands., van der Burg SH; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., van Hall T; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., van Montfoort N; Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands nvanmontfoort@lumc.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jul; Vol. 10 (7).
Autor:
Pépin J; Department of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, Québec, Canada., Desjardins F; Clinique des Réfugiés, Centre Local de Services Communautaires, Sherbrooke, Québec, Canada., Carignan A; Department of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, Québec, Canada., Lambert M; Clinique des Réfugiés, Centre Local de Services Communautaires, Sherbrooke, Québec, Canada., Vaillancourt I; Clinique des Réfugiés, Centre Local de Services Communautaires, Sherbrooke, Québec, Canada., Labrie C; Clinique des Réfugiés, Centre Local de Services Communautaires, Sherbrooke, Québec, Canada., Mercier D; Clinique des Réfugiés, Centre Local de Services Communautaires, Sherbrooke, Québec, Canada., Bourque R; Clinique des Réfugiés, Centre Local de Services Communautaires, Sherbrooke, Québec, Canada., LeBlanc L; Department of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Publikováno v:
PloS one [PLoS One] 2022 May 19; Vol. 17 (5), pp. e0267781. Date of Electronic Publication: 2022 May 19 (Print Publication: 2022).
Autor:
Beyranvand Nejad E; Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., Labrie C; Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., van Elsas MJ; Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., Kleinovink JW; Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., Mittrücker HW; Department of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Franken KLMC; Department of Immunology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., Heink S; Experimental Neuroimmunology, Technische Universität München, Munchen, Bayern, Germany., Korn T; Experimental Neuroimmunology, Technische Universität München, Munchen, Bayern, Germany., Arens R; Department of Immunology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., van Hall T; Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., van der Burg SH; Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands shvdburg@lumc.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Apr; Vol. 9 (4).
Autor:
Fedotcheva, Tatiana A.1 (AUTHOR) m.uspenskaja@mail.ru, Uspenskaya, Maria E.1 (AUTHOR), Ulchenko, Darya N.1 (AUTHOR), Shimanovsky, Nikolay L.1 (AUTHOR)
Publikováno v:
Pharmaceuticals (14248247). Sep2024, Vol. 17 Issue 9, p1186. 24p.